COMP <GO>
PWR vs TMO // GROSS PROFIT MARGIN
Quanta Services Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PWR 3
— TMO 11
▲ GROSS PROFIT MARGIN LEADER: TMO
LAST: $620.73 (-2.27%) • MKT CAP: $93.58B
gross-margins
15.00%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
gross-margins
41.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PWR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PWR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 15.00% | 41.00% | -26.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.40% | 9.30% | -0.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 46.9x | 30.4x | +16.50 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.73% | 2.40% | -0.67 | TMO | /fcf-yield <GO> |
| Operating Margin | 5.70% | 17.40% | -11.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.70% | 15.10% | -11.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 20.30% | 3.90% | +16.40 | PWR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.06% | 0.24% | -0.18 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.32 | 4.50 | +0.82 | PWR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 59.1 | -10.24 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | PWR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 75.4x | 36.3x | +39.10 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $93.58B | $262.22B | -$168.64B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PWR REV | TMO REV | PWR GROSS % | TMO GROSS % | PWR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.48B | $44.56B | 15.0% | 44.0% | $1.62B | $6.29B |
| FY 2024 | $23.67B | $42.88B | 14.8% | 44.0% | $1.48B | $7.27B |
| FY 2023 | $20.88B | $42.86B | 44.0% | 44.0% | $636.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PWR // BETA 1.01
TMO // BETA 0.94